EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Auna S.A. (AUNA) fair value: what the stock is really worth

As of Oct 22, 2026: fair value (intrinsic value) of Auna S.A. stock $15.09, price $5.03, upside +200.0%, quality 31 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? No
  3. Add to watchlist

Healthcare · US · Based in Germany · ISIN LU2791994721

AS Auna S.A. logo Some data Oct 4, 2026

Auna S.A.

AUNA · US

Cheap, value-trap riskThe stock looks deeply undervalued, but low quality raises value-trap risk.

The stock costs 67% less than our calculation considers fair.

Fair value $15.09 · Strongly undervalued (+200.0%)
Healthy Growth (revenue 5y +24.9 %/yr in PEN)
Generates free cash flow
Thin margins · 0.4% net margin (TTM)
Mixed vs. peers (6/12)
Some data
Quality 31/100
High debt
Narrow moat 28/100 · thin data

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$10.66 $4.15 Fair Value $15.09 Mar 2024 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 4, 2026.

How to read this chart

31‑month range $4.15 – $10.66 · fair‑value band $7.49 – $22.69 · the $5.03 price screens below the $15.09 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. Dashed = 300-day average. As of Oct 4, 2026.

Follow Auna in your weekly email

Every Wednesday you see whether Auna is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Auna S.A., a healthcare service provider, operates hospitals and clinics in Mexico, Peru, and Colombia. The company provides prepaid healthcare; dental and vision insurance; and oncology plans. It also sells medicines. Auna S.A. was founded in 1989 and is based in Luxembourg, Luxembourg.

Stock analysis

Auna S.A. (AUNA) currently trades at $5.03, while our model-based Fair Value estimate is $15.09, implying the stock looks roughly 66.7% undervalued today.

Show more

Valuation

Bull case: the Growth DCF group reads highest at a median of $37.19 per share, and 21 of the 22 models we run sit above the $5.03 price.

Bear case: the Economic Profit group reads lowest at $4.90, and 1 of the 22 models stay below the price. Data coverage for this calculation is medium.

Scenario range: $7.49 (bear) to $22.69 (bull), the price of $5.03 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 31/100 (below-average quality), in the Healthcare sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Auna S.A. reported revenue of 4.4B PEN in FY2025 versus 1.9B PEN in FY2021, a compound +22.9%/yr. Reported net income was 97.6M PEN in FY2025.

Key figures

Market cap $372M Small · P/E ratio 84.3 · P/S ratio 0.08 · EPS (TTM) $0.0600 · Net margin 0.4% · Return on equity 1.6% · Return on assets (EBIT) 6.9% · Operating margin 13.1%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 28 out of 100 (low confidence).

What moves the price

The share trades about 20% below its 52-week high and 21% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 3% fair-value upside, at 200%, AUNA screens cheaper than that median.

Fair Value models

Bear $7.49 Fair Value $15.09 Bull $22.69
Price $5.03 · Upside +200.0%
Capped: our models arrive at a very high value here. We deliberately show a more cautious Fair Value.
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then ($0.0487 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
Residual Income $4.80 $4.90 $5.25 75
FCF DCF $17.75 $35.61 $83.44 72
EPV $7.00 $9.71 $12.01 72
All 22 models by family
DCF Models
FCF DCF $17.75 $35.61 $83.44 72
Owner Earnings $18.59 $52.59 $118.26 68
5Y Revenue Exit $13.84 $34.85 $74.75 66
5Y EBITDA Exit $20.86 $50.11 $102.36 69
5Y P/E Exit $1.92 $10.29 $20.23 64
10Y Revenue Exit $14.04 $38.60 $68.50 62
10Y EBITDA Exit $19.55 $51.08 $108.00 62
10Y P/E Exit $6.92 $17.39 $33.27 59
Earnings-Based
Graham-Dodd $2.61 $18.07 $25.35 60
Lynch FV $5.33 $7.61 $9.89 58
PEG = 1.0 $5.33 $7.61 $9.89 55
EPV $7.00 $9.71 $12.01 72
Multiples
P/E Multiple $6.34 $8.45 $10.57 61
P/S Multiple $4.90 $6.53 $8.17 56
EV/EBIT $18.61 $29.18 $39.74 63
EV/EBITDA $21.69 $33.28 $44.86 65
EV/Revenue $9.54 $19.24 $28.93 50
Growth DCF
Growth DCF $16.35 $39.39 $79.96 71
Rev-Margin DCF $13.84 $37.19 $71.84 67
Economic Profit
Residual Income $4.80 $4.90 $5.25 75
ROIC Compounder $7.57 $14.38 $20.32 69
Growth Earnings
Growth-Adj P/E $7.46 $10.66 $13.85 66

Open the full fair value analysis →

Quality Score breakdown

Overall quality 31/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 32
How much profit the company makes from its sales and capital
Quality Growth 37
Are margins and returns getting better?
Cashflow 53
Do the profits arrive as real cash?
Financial strength 9
Debt, balance sheet and risk of trouble
Investment 70
Does it invest with discipline instead of growing at any price?
Low Volatility 64
How calm the share price moves, does not count
Momentum 32
Price trend of the last 3 to 12 months, does not count
Near the 52-week high 26
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 85/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+0.0%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+21.4%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+24.9%
Start year 2020 (pandemic)
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+25.3%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+13.9%
Earnings growth per share plus dividend.
Earnings per share, growth per year+13.9%
Dividend (yield on the price)0.0%
Profit margin 2019 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.12% → 14%

Growth Forecast

A lot of optimism in the price
The price assumes less growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+16.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+5.8%
Yearly sales growth analysts expect, extended to five years.
After inflation (figures in PEN, Peru: IMF forecast 2.1% a year to 2030, 3.4% from 2016 to 2025) that is about +14.3% a year for the price and +3.7% for the forecasts.
Forecast 2026 (sales)+10.9%
Forecast 2027 (sales)+5.2%
Projected 2028 (sales)+4.8%
Projected 2029 (sales)+4.4%
Projected 2030 (sales)+4.0%

Watch AUNA, get fair value alerts →

Compare Auna S.A. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 244 stocks

Beats the industry median on 5/11 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 31 · Bottom 25%
Profitability
Return on equity (12 months) 1.6% · Below median
Return on assets 1.3% · Below median
Net margin (12 months) 0.4% · Bottom 25%
Operating margin (12 months) 13.1% · Above median
Growth and dividend
Revenue growth (quarter YoY) 13.2% · Above median
Balance sheet
Debt / equity 2.01× · Highest 25%

Valuation Multiplesvs Medical Care Facilities median · lower = cheaper

P/E (12 months) 84.3× · Priciest 25%
P/B 0.86× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (12 months) 0.30× · Cheapest 25%
Price / free cash flow 8.5× · Cheaper than median
EV/EBITDA 5.4× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 36
FUTURE (revenue growth)66 · sector 28
PAST (return on equity)6 · sector 32
HEALTH (low debt)0 · sector 90
DIVIDEND (yield)0 · sector 40

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.

Explore undervalued stocks

More undervalued Healthcare stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Auna S.A. Fair Value". https://www.fairvalue-calculator.com/stock/AUNA

Frequently asked questions

Is Auna S.A. (AUNA) overvalued or undervalued?
As of Oct 4, 2026, our model estimates a fair value of $15.09 versus a price of $5.03, about +200% upside (undervalued).
What is the fair value of AUNA?
Our model-based fair value for Auna S.A. is $15.09 (as of Oct 4, 2026), built from audited fundamentals. The current price: $5.03.
What is the quality score of AUNA?
Auna S.A. has a Quality Score of 31/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Auna S.A. (AUNA)?
Our model-based price target is the fair value of $15.09 (as of Oct 4, 2026) from 22 valuation models. Cautious scenario $7.49, optimistic scenario $22.69. It is a calculation from audited fundamentals, not an analyst target.
What is the Auna S.A. stock forecast for 2026?
Our models put fair value at $15.09, about +200% upside versus a price of $5.03 (undervalued). Cautious scenario $7.49, optimistic scenario $22.69. The calculation is refreshed regularly with new filings.
What is the revenue of Auna S.A. (AUNA)?
Auna S.A. reported trailing-twelve-month revenue of about 4.7B PEN (latest available figure, as of Oct 4, 2026).
What growth is priced into Auna S.A. (AUNA)?
For today's price to be fair in a discounted-cash-flow model, Auna S.A. would have to grow free cash flow by +16.7 % per year for five years (discount rate 10.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +24.9 % per year. As of Oct 4, 2026.
What discount rate (WACC) does the fair value of AUNA use?
Our models discount Auna S.A. at 10.2 %: a base by market capitalisation (small), damped by beta 0.62, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Auna S.A. that is +16.7 % per year a year over ten years, using the same discount rate (10.2 %) and the same formula as our fair value.
How much growth has Auna S.A. (AUNA) delivered so far?
Over the past 5 years revenue at Auna S.A. grew +24.9 % a year. The price currently implies +16.7 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Auna S.A. (AUNA) growing?
The median revenue growth in the sector is +5.6 % a year. That is the yardstick for the growth priced into Auna S.A. (+16.7 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Auna S.A. (AUNA)?
The free-cash-flow yield on the price is 12.58 %: that much free cash flow Auna S.A. produces per unit of market value. When it exceeds the discount rate of our models (10.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Auna S.A. (AUNA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Auna S.A. it is $15.09 per share (as of Oct 4, 2026), against a price of $5.03. It is the blended result of 22 valuation models (cash flow, earnings, asset, dividend).
Is Auna S.A. stock overvalued or undervalued in 2026?
As of Oct 4, 2026, AUNA trades below its calculated fair value: price $5.03, fair value $15.09, a gap of about +200% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of AUNA?
No. The price is what the market pays today ($5.03); the fair value is what the company's own numbers justify ($15.09). For Auna S.A. the two are $10.06 per share apart. That gap is exactly why we show both numbers side by side.
How much is Auna S.A. worth?
The market values Auna S.A. at about $372M (market capitalisation, as of Oct 4, 2026). Per share that is $5.03; our models calculate a fair value of $15.09 per share.
What do the bullish and bearish scenarios say about AUNA?
Our models span a range for Auna S.A.: cautious scenario $7.49, base $15.09, optimistic $22.69 per share (as of Oct 4, 2026, price $5.03). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of AUNA?
Auna S.A. trades at a price-to-earnings ratio of 84.3 (as of Oct 4, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $15.09 is built from several models across several years. Other multiples: P/B 0.9, P/S 0.3, EV/EBITDA 5.4.
How solid is the balance sheet of Auna S.A. (AUNA)?
Balance-sheet figures for Auna S.A. (as of Oct 4, 2026): return on equity 1.6%, debt of 2.01 per unit of equity. They feed the Quality Score of 31/100, which measures business quality independently of the share price.
How far is AUNA from its 52-week high?
Auna S.A. trades at $5.03, about 20% below its 52-week high of $6.26 and 21% above the low of $4.15 (as of Oct 22, 2026). Distance from the high says nothing about value: that is what the fair value of $15.09 is for.
Which stocks are comparable to Auna S.A.?
From the same area (Healthcare) we also value HCA Healthcare, Inc, Fresenius SE, Tenet Healthcare Corporation, Dr. Sulaiman Al Habib Medical Services Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Auna S.A. stock attractive at the current price?
The data as of Oct 4, 2026: price $5.03, calculated fair value $15.09 (+200%), Quality Score 31/100, from 22 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of AUNA calculated?
We run Auna S.A. through 22 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $15.09, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.2 % above its aggregate fair value. Auna S.A. currently trades 67 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Auna S.A. (AUNA)?
The closing price on Oct 22, 2026 was $5.03. Our model-based fair value is $15.09, about +200% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Auna S.A. right now?
The large discount to fair value meets weak quality (31/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case ($7.49). The market is more pessimistic than our downside scenario. The model range is unusually wide ($7.49 to $22.69). The outcome hinges heavily on assumptions, so read the point estimate with caution.

Key figures of Auna S.A.

How large is the market capitalisation of Auna S.A. (AUNA)?
The market capitalisation of Auna S.A. is $372M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Auna S.A. (AUNA)?
The price-to-sales ratio of Auna S.A. is 0.08 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Auna S.A. (AUNA)?
Earnings per share at Auna S.A. are $0.0600 (price ÷ EPS = P/E 84.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Auna S.A. (AUNA)?
The net margin of Auna S.A. is 0.4% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Auna S.A. (AUNA)?
The return on equity (ROE) of Auna S.A. is 1.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Auna S.A. (AUNA)?
On an EBIT basis the return on assets of Auna S.A. is 6.9% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Auna S.A. (AUNA)?
The operating margin of Auna S.A. is 13.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Auna S.A. (AUNA)?
Revenue at Auna S.A. is growing +13.2% versus a year earlier (3y avg +21.4%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Auna S.A. (AUNA)?
Earnings per share at Auna S.A. are growing −64.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Auna S.A. (AUNA) carry?
The net debt of Auna S.A. is 3.3B PEN (fiscal year 2025, ≈ 20.5 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Continue in the live analysis

Fair value and trend for 35,000+ stocks, watchlist, comparison and the diversification check.

Open the live analysis →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.